<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Carli V</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Electrodermal hyporeactivity has been proposed as a marker of suicidal risk. The EUDOR-A study investigated the prevalence of electrodermal hyporeactivity among patients with depression and its association with attempted and completed suicide. &lt;b>Methods:&lt;/b> Between August 2014 and March 2016, 1,573 in- and outpatients with a primary diagnosis of depression (active or remission phase) were recruited at 15 European psychiatric centers. Each patient was followed-up for 1 year. Electrodermal activity was assessed at baseline with the ElectroDermal Orienting Reactivity Test. Data on the sociodemographic characteristics, clinical diagnoses, and treatment of the subjects were also collected. The severity of the depressive symptoms was assessed through the Montgomery-Asberg De</pubmed_abstract><journal>Frontiers in psychiatry</journal><pagination>765128</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8766803</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Naturalistic, European Multi-Center Clinical Study of Electrodermal Reactivity and Suicide Risk Among Patients With Depression.</pubmed_title><pmcid>PMC8766803</pmcid><pubmed_authors>Di Sciascio G</pubmed_authors><pubmed_authors>Ekstrand J</pubmed_authors><pubmed_authors>Amore M</pubmed_authors><pubmed_authors>Carli V</pubmed_authors><pubmed_authors>Petros NG</pubmed_authors><pubmed_authors>Jesus C</pubmed_authors><pubmed_authors>Wojnar M</pubmed_authors><pubmed_authors>Constante M</pubmed_authors><pubmed_authors>Heitor MJ</pubmed_authors><pubmed_authors>Courtet P</pubmed_authors><pubmed_authors>Iosue M</pubmed_authors><pubmed_authors>Gramaglia C</pubmed_authors><pubmed_authors>Baca-Garcia E</pubmed_authors><pubmed_authors>Saiz PA</pubmed_authors><pubmed_authors>Sarchiapone M</pubmed_authors><pubmed_authors>Zeppegno P</pubmed_authors><pubmed_authors>Hadlaczky G</pubmed_authors><pubmed_authors>Cosman D</pubmed_authors><pubmed_authors>Rad PM</pubmed_authors><pubmed_authors>Batra A</pubmed_authors><pubmed_authors>Galfalvy H</pubmed_authors><pubmed_authors>Gusmao R</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Naturalistic, European Multi-Center Clinical Study of Electrodermal Reactivity and Suicide Risk Among Patients With Depression.</name><description>&lt;b>Background:&lt;/b> Electrodermal hyporeactivity has been proposed as a marker of suicidal risk. The EUDOR-A study investigated the prevalence of electrodermal hyporeactivity among patients with depression and its association with attempted and completed suicide. &lt;b>Methods:&lt;/b> Between August 2014 and March 2016, 1,573 in- and outpatients with a primary diagnosis of depression (active or remission phase) were recruited at 15 European psychiatric centers. Each patient was followed-up for 1 year. Electrodermal activity was assessed at baseline with the ElectroDermal Orienting Reactivity Test. Data on the sociodemographic characteristics, clinical diagnoses, and treatment of the subjects were also collected. The severity of the depressive symptoms was assessed through the Montgomery-Asberg De</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-26T15:59:57.767Z</modification><creation>2025-04-26T15:59:57.767Z</creation></dates><accession>S-EPMC8766803</accession><cross_references><pubmed>35069276</pubmed><doi>10.3389/fpsyt.2021.765128</doi></cross_references></HashMap>